KBLB Kraig Biocraft Laboratories Inc.

Kraig Biocraft Laboratories Achieves Breakthrough In Recombinant Spider Silk Design Complexity

Kraig Biocraft Laboratories Achieves Breakthrough In Recombinant Spider Silk Design Complexity

Paving the Way for Advanced Material Performance

ANN ARBOR, Mich., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Kraig Labs" or "the Company"), a leading developer of spider silk-based fibers, today announced a significant breakthrough in its genetic research program. The Company's research team has successfully doubled the complexity and size of its spider silk gene insert package; a milestone expected to drive new advancements in material performance.

Building on its pioneering work in recombinant spider silk production, the Company’s latest achievement represents a major step forward in the development of next-generation fibers. By expanding the gene insert package, Kraig Labs aims to create more advanced silk materials with improved strength, elasticity, and durability—critical attributes for high-performance applications in technical textiles, defense, and medical industries.

"We believe that larger and more complex gene insert packages hold the potential to unlock superior material characteristics in our spider silk fibers," said Kim Thompson, CEO and Founder of Kraig Labs. "This breakthrough reinforces our leadership in biomaterials innovation and sets the stage for the next evolution of spider silk technology."

While this cutting-edge research progresses in the lab, Kraig Labs remains committed to bringing its revolutionary spider silk fibers to market. The Company's production team continues its focus on commercial-scale spider silk manufacturing, with targeted material sales into multiple markets. Kraig Labs expects this will be a pivotal year for industry integration of spider silk.

"Our production team is on track to deliver commercial quantities of our spider silk this year, even as our research team pushes the boundaries of what's possible in the lab," added the Company’s COO, Jon Rice. "We are strategically balancing innovation and production to meet the growing demand for our game-changing materials."

With its dual focus on both research and commercialization, Kraig Labs is solidifying its position as a global leader in spider silk technology. The Company remains dedicated to transforming the future of performance materials with bioengineered spider silk.

For details about other recent Kraig Labs advancements, please watch the Company's investor conference at or on the Company's YouTube Channel .

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to .  

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (), a reporting biotechnology company, is the leading developer of genetically engineered spider silk-based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "estimated," "hopes," "if," "develops," "researching," "research," "pilot," "potential," "could" or other words or phrases of similar import. Forward looking statements include descriptions of the Company's business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

Photos accompanying this announcement are available at:



EN
26/02/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Kraig Biocraft Laboratories Inc.

 PRESS RELEASE

24/7 Market News - Not Magic, Just Science: Kraig Labs’ Transgenic Sil...

24/7 Market News - Not Magic, Just Science: Kraig Labs’ Transgenic Silkworms Make History at Scale Kraig Labs Cracks the Spider Silk Code DENVER, Feb. 11, 2026 (GLOBE NEWSWIRE) -- , a pioneer in digital media dedicated to the swift distribution of financial market news and information, reports that Kraig Biocraft Laboratories (OTCQB: KBLB) (“the Company” or “Kraig Labs”), the undisputed global leader in the development and commercialization of spider silk, is entering a new phase of commercial scale-up as it accelerates production to meet growing demand from global brands. Kraig Labs u...

 PRESS RELEASE

Kraig Biocraft Laboratories Poised for Explosive Spider Silk Productio...

Kraig Biocraft Laboratories Poised for Explosive Spider Silk Production Growth 2026 Production Plan Set for a Record 10 Metric Tons of Recombinant Spider Silk Cocoon Per Month ANN ARBOR, Mich., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's"), a world leader in spider silk technology*, today announced its 2026 production plan that will drive explosive growth and establish a new global benchmark for spider silk manufacturing. Kraig's technology is built upon the use of modified silkworms to produce recombinant ...

 PRESS RELEASE

Control the Stack, Control the Future: The New Era of Supply-Chain Pow...

Control the Stack, Control the Future: The New Era of Supply-Chain Power DENVER, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Innovation still rules, but ownership of the entire supply-chain pipeline is becoming the next biggest strategic advantage in today’s markets. From raw inputs to final delivery, companies that control their supply chains are increasingly the ones dictating price, pace, and profit. SpaceX’s acquisition of xAI is the latest and, perhaps boldest, proof of that thesis. When SpaceX announced it had formally acquired xAI, Elon Musk framed it not as a merger, but as a turning point...

 PRESS RELEASE

The Real Ironman Economy: How AI, Superfibers, and Defense Tech Could ...

The Real Ironman Economy: How AI, Superfibers, and Defense Tech Could Theoretically Converge DENVER, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Recent reports that Palantir Technologies (NASDAQ: PLTR) has been tapped by President Trump to deploy AI systems to hunt fraud, likened in headlines to an AI “Ironman suit”, have reignited interest in how far advanced technology can really go. While the phrase is metaphorical, the underlying idea is very real: software, materials, and hardware are converging to augment human capability in ways that once sounded like science fiction. So, what if Palantir, ...

 PRESS RELEASE

Kraig Biocraft Laboratories Rings in the New Year with the Most Ambiti...

Kraig Biocraft Laboratories Rings in the New Year with the Most Ambitious Genetic Engineering Program in its History ANN ARBOR, Mich., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's"), a world leader in spider silk technology*, today announced that it is entering the new year with the implementation of the most ambitious and advanced genetic engineering initiative ever undertaken by the Company. The focus of this project is to dramatically increase strength and elasticity beyond anything ever seen in the area of ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch